Abstract:The burden of breast cancer continues to increase worldwide as it remains the most diagnosed tumor in females and the second leading cause of cancer-related deaths. Breast cancer is a heterogeneous disease characterized by different subtypes which are driven by aberrations in key genes such as BRCA1 and BRCA2 , and hormone receptors. However, even within each subtype, heterogeneity that is driven by underlying evolutionary mechanisms is suggested to underlie poor response to therapy, variance in disease progression, recurrence, and relapse. Intratumoral heterogeneity highlights that the evolvability of tumor cells depends on interactions with cells of the tumor microenvironment. The complexity of the tumor microenvironment is being unraveled by recent advances in screening technologies such as high throughput sequencing; however, there remain challenges that impede the practical use of these approaches, considering the underlying biology of the tumor microenvironment and the impact of selective pressures on the evolvability of tumor cells. In this review, we will highlight the advances made thus far in defining the molecular heterogeneity in breast cancer and the implications thereof in diagnosis, the design and application of targeted therapies for improved clinical outcomes. We describe the different precision-based approaches to diagnosis and treatment and their prospects. We further propose that effective cancer diagnosis and treatment are dependent on unpacking the tumor microenvironment and its role in driving intratumoral heterogeneity. Underwriting such heterogeneity are Darwinian concepts of natural selection that we suggest need to be taken into account to ensure evolutionarily informed therapeutic decisions.

New Insights from the Widening Homogeneity Perspective to Target Intratumor Heterogeneity

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

Tumor Heterogeneity: the Challenge of Precision Medicine

Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses

Intratumor Heterogeneity: A New Perspective on Colorectal Cancer Research

Correction: Breast Cancer Heterogeneity and Its Implication in Personalized Precision Therapy

A Richer Understanding of Intratumoral Heterogeneity: Single-Cell Genomics Put It Within Reach

Intratumor Heterogeneity As an Opportunity for Drug Sensitivity Prediction and Biomarker Discovery.

A population genetics perspective on the determinants of intra-tumor heterogeneity

Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy

Precision medicine and bladder cancer heterogeneity

Lung Cancer Heterogeneity and New Strategies for Drug Therapy.

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Intratumoral Heterogeneity of Hepatocellular Carcinoma: from Single-Cell to Population-Based Studies

Intratumor heterogeneity alters most effective drugs in designed combinations

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

Systems Heterogeneity: an Integrative Way to Understand Cancer Heterogeneity.

Progress in the Clinical Detection of Heterogeneity in Breast Cancer.

Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches

Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment